IRIS
LOSURDO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.093
AS - Asia 2.811
EU - Europa 1.833
SA - Sud America 693
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 12.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.970
SG - Singapore 1.137
BR - Brasile 556
CN - Cina 550
RU - Federazione Russa 375
HK - Hong Kong 363
SE - Svezia 330
IT - Italia 257
DE - Germania 246
VN - Vietnam 237
FR - Francia 149
GB - Regno Unito 130
FI - Finlandia 102
IN - India 95
BD - Bangladesh 75
CA - Canada 58
IQ - Iraq 55
ID - Indonesia 54
BE - Belgio 51
AR - Argentina 46
TR - Turchia 42
MX - Messico 39
PL - Polonia 32
ZA - Sudafrica 32
PK - Pakistan 31
CO - Colombia 30
NL - Olanda 27
ES - Italia 26
UA - Ucraina 25
UZ - Uzbekistan 22
EC - Ecuador 20
SA - Arabia Saudita 20
JP - Giappone 19
IE - Irlanda 14
MA - Marocco 14
EG - Egitto 13
PH - Filippine 13
VE - Venezuela 12
AT - Austria 11
DZ - Algeria 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
JO - Giordania 9
TN - Tunisia 9
MY - Malesia 8
AL - Albania 7
GR - Grecia 7
KE - Kenya 7
KZ - Kazakistan 7
AU - Australia 6
CL - Cile 6
IL - Israele 6
KR - Corea 6
LB - Libano 6
NP - Nepal 6
RO - Romania 6
BO - Bolivia 5
CH - Svizzera 5
EU - Europa 5
JM - Giamaica 5
LT - Lituania 5
PY - Paraguay 5
TH - Thailandia 5
BG - Bulgaria 4
MK - Macedonia 4
PA - Panama 4
QA - Qatar 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
GA - Gabon 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
IR - Iran 2
KW - Kuwait 2
MD - Moldavia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AM - Armenia 1
BJ - Benin 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
Totale 12.540
Salva come PNG Salva come JPEG
Città #
Fairfield 869
Ashburn 796
Woodbridge 626
Singapore 608
Chandler 449
Houston 376
San Jose 374
Hong Kong 360
Seattle 337
Wilmington 298
Cambridge 293
Ann Arbor 286
Nyköping 278
Beijing 201
New York 147
Dallas 134
Council Bluffs 109
Lawrence 88
Jacksonville 85
Roxbury 85
Los Angeles 81
Lauterbourg 78
Ho Chi Minh City 71
Nanjing 67
Munich 60
Helsinki 54
Inglewood 54
Des Moines 53
Brussels 51
São Paulo 49
Bari 48
Hanoi 45
Princeton 39
Santa Clara 38
Brooklyn 37
Jakarta 35
Buffalo 33
Frankfurt am Main 32
Dearborn 31
San Diego 31
Atlanta 27
Chicago 27
Warsaw 26
Falkenstein 23
Milan 23
Nuremberg 21
Orem 21
Denver 20
Montreal 20
Dong Ket 19
London 19
Rio de Janeiro 19
Baghdad 18
Dhaka 18
Hebei 18
Paris 18
Tashkent 18
Tokyo 18
Belo Horizonte 17
Johannesburg 17
The Dalles 17
Boardman 16
Columbus 16
Mexico City 16
Nanchang 16
Haiphong 15
Stockholm 15
Jiaxing 14
San Francisco 14
Tianjin 14
Brasília 13
Chennai 13
Dublin 13
Istanbul 13
Medellín 13
Shenyang 13
Toronto 13
Pune 12
Boston 11
Curitiba 11
Da Nang 11
Lahore 11
Cairo 10
Phoenix 10
Abidjan 9
Poplar 9
Redwood City 9
Amman 8
Amsterdam 8
Ankara 8
Baku 8
Buenos Aires 8
Guangzhou 8
Hefei 8
Maringá 8
New Delhi 8
Porto Alegre 8
Riyadh 8
Salvador 8
Turku 8
Totale 8.644
Salva come PNG Salva come JPEG
Nome #
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 204
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 195
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 195
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 191
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 185
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 182
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 181
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 180
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 179
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 162
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 154
Curcumin and colorectal cancer: From basic to clinical evidences 148
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 147
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 139
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 138
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 138
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 137
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 131
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 127
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 126
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 126
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 122
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 121
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 121
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 115
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 115
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 113
An uncommon etiology of pancreatitis after endoscopic ultrasound-guided fine needle aspiration 110
Seronegative celiac disease: where is the specific setting? 107
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 106
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 104
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 103
Checkpoint Inhibitor-Induced Colitis: An Update 101
null 101
null 100
Human leukocyte antigen (Hla) haplotype does not influence the inflammatory pattern of duodenal lymphocytosis linked to irritable bowel syndrome 100
null 99
Endoscopic stenting for colorectal cancer obstruction as a bridge-to-surgery strategy 99
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 99
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis 98
Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study 95
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 95
The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders 95
null 94
Might helicobacter pylori play a role in allergic or cross-reaction related disorders? 94
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 94
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 93
Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study 91
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 91
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 91
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 91
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 88
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 87
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 87
null 86
null 86
null 85
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 85
Liver involvement in inflammatory bowel disease: What should the clinician know? 84
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 84
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 84
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 84
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 83
null 82
Estrogen receptors in colorectal cancer: Facts, novelties and perspectives 82
null 81
null 81
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 81
null 80
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation—Authors’ reply 80
null 79
null 79
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 79
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 74
null 74
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 74
null 73
null 73
Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages 73
Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation 73
null 72
null 72
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy 71
null 71
null 71
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 71
null 70
null 70
null 70
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 69
null 69
null 69
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 68
null 67
Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept 67
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors? 67
null 66
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 65
Fibres and Colorectal Cancer: Clinical and Molecular Evidence 65
Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis 65
Totale 10.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 0 0 0 0 148 51 80
2021/2022670 66 10 14 17 45 70 20 32 52 62 115 167
2022/20231.115 148 187 85 74 90 169 21 134 152 5 32 18
2023/2024416 29 69 16 47 26 137 6 7 2 34 8 35
2024/20252.039 56 25 106 32 38 183 297 210 93 136 285 578
2025/20264.578 724 242 332 470 641 215 484 149 785 536 0 0
Totale 13.129